Skip to main content
BBIO logo

BBIO · BridgeBio Pharma, Inc.

$84.12 +0.10 (+0.12%) At close · Jul 27
Market Cap
$16.48B
Shares
195.86M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 467
Total Value: $14,699,982,170
Total Shares: 197,948,992
Showing 1–100 of 497 holdings by value · page 1 of 5

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 463 13F filers
Top Holder
7.2%
Jun 2023 → Mar 2026 · range 7.2% – 19.3%
of institutional value
Top 5
31.2%
Jun 2023 → Mar 2026 · range 31.2% – 53.5%
of institutional value
Top 10
45.7%
Jun 2023 → Mar 2026 · range 45.7% – 66.8%
of institutional value
HHI
293
Jun 2023 → Mar 2026 · range 293 – 815
Broadly held
Showing 100 of 497
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1743881 CUSIP 10806X102 13F (30d) 85 filings 84 filers Visit website Investor relations